{"title":"处方者和政策制定者应该了解美国药品进口的哪些情况？","authors":"Nisha Quasba, Elliot Vice","doi":"10.1001/amajethics.2024.295","DOIUrl":null,"url":null,"abstract":"Drug importation raises several ethical and safety concerns relevant to prescribers and policy makers considering costs and benefits of international medicine importation. This article suggests key points to consider, especially from a policy perspective, when weighing imported medicines' perceived affordability and accessibility against additional resource expenditure needed to assure sufficient regulatory oversight and equitable distribution and to mitigate potential risks of harm to patients.","PeriodicalId":505099,"journal":{"name":"AMA Journal of Ethics","volume":"259 1","pages":"E295-302"},"PeriodicalIF":0.0000,"publicationDate":"2024-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"What Should Prescribers and Policy Makers Know About US Drug Importation?\",\"authors\":\"Nisha Quasba, Elliot Vice\",\"doi\":\"10.1001/amajethics.2024.295\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Drug importation raises several ethical and safety concerns relevant to prescribers and policy makers considering costs and benefits of international medicine importation. This article suggests key points to consider, especially from a policy perspective, when weighing imported medicines' perceived affordability and accessibility against additional resource expenditure needed to assure sufficient regulatory oversight and equitable distribution and to mitigate potential risks of harm to patients.\",\"PeriodicalId\":505099,\"journal\":{\"name\":\"AMA Journal of Ethics\",\"volume\":\"259 1\",\"pages\":\"E295-302\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-04-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"AMA Journal of Ethics\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1001/amajethics.2024.295\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"AMA Journal of Ethics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1001/amajethics.2024.295","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
What Should Prescribers and Policy Makers Know About US Drug Importation?
Drug importation raises several ethical and safety concerns relevant to prescribers and policy makers considering costs and benefits of international medicine importation. This article suggests key points to consider, especially from a policy perspective, when weighing imported medicines' perceived affordability and accessibility against additional resource expenditure needed to assure sufficient regulatory oversight and equitable distribution and to mitigate potential risks of harm to patients.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
